Isolating human antibody against human hepatocellular carcinoma by guided-selection

Cancer Biology and Therapy

Volumn 4, Issue 12, 2005, Pages 1374-1380

  Bao, Guo Qiang ^a   Li, Yu ^b   Ma, Qing Jiu ^a   He, Xian Li ^a   Xing, Jin Liang ^b   Yang, Xiang Min ^b   Chen, Zhi Nan ^b,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Cell Engineering Research Centre   (China)

Author keywords

Biological therapy; Chain shuffling; Guided selection; HAb18G CD147; Hepatocellular carcinoma; Human antibody; Phage antibody library

Indexed keywords

ANTIGEN; CANCER ANTIBODY; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; RECOMBINANT PROTEIN;

ANTIBODY AFFINITY; ANTIBODY ISOLATION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GENE CONSTRUCT; GENE LIBRARY; HEAVY CHAIN; HUMAN; HUMAN CELL; LIGHT CHAIN; LIVER CELL CARCINOMA; MEDICAL RESEARCH; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

EID: 31144443118     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.12.2273     Document Type: Article

References (32)

1. Choi JY. Experimental treatment of hepatocellular carcinoma. Korean J Gastroenterol 2005; 45:271-6.
2. Qian SB, Li Y, Qian GX, Chen SS. Efficient tumor regression induced by genetically engineered tumor cells secreting interleukin-2 and membrane-expressing allogeneic MHC class I antigen. J Cancer Res Clin Oncol 2001; 127:27-33.
3. Dai WJ, Jiang HC. Advances in gene therapy of liver cirrhosis: A review. World J Gastroenterol 2001; 7:1-8.
4. Winter G, Harris WJ. Humanized antibodies. Immunol Today 1993; 14:243-6.
5. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 1984; 81:6851-5.
6. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986; 32:522-5.
7. Holliger P, Hoogenboom H. Antibodies come back from the brink. Nat Biotechnol 1998; 16:1015-6.
8. Jespers LS, Roberts A, Mahler SM, Winter G, Hoogenboom HR. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology (NY) 1994; 12:899-903.
9. Figini M, Marks JD, Winter G, Griffiths AD. In vitro assembly of repertoires of antibody chains on the the surface of phage by renaturation. J Mol Biol 1994; 239:68-78.
10. Wang Z, Wang Y, Li Z, Li J, Dong Z. Humanization of a mouse monoclonal antibody neutralizing TNF-alpha by guided selection. J Immunol Methods 2000; 241:171-84.
11. Bao GQ, Ma QJ, Xing JL, Yang XM, Chen ZN. Preparation of human Fab antibodies against HAb18G by guided selection and chain shuffling technique. In: Bao XI, Fen YU, Mian ZI, Xue YI, Zhi ZA, eds. 2004:20:437-40.
12. Reason DC, Wagner TC, Lucas AH. Human Fab fragments specific for the haemophilus influenzae b polysaccharide isolated from a bacteriophage combinatorial library use variable region gene combinations and express an idiotype that mirrors in vivo expression. Infect Immun 1997; 65:261-6.
13. Marks JD, Tristem M, Karpas A, Winter G. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol 1991; 21:985-91.
14. Persson MA, Caothien RH, Burton DR. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc Natl Acad Sci USA 1991; 88:2432-6.
15. de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bruine AP, Arends JW, Hoogenboom HR. A large nonimmunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem 1999; 274:18218-30.
16. Berry JD, Rutherford J, Sliverman GJ, Kaul R, Elia M, Gobuty S, Fuller R, Plummer FA, Barbas IIIrd CF. Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells. Hybrid Hybridomics 2003; 22(2):97-108.
17. de Bruin R, Spelt K, Mol J, Koes R, Quattrocchio F. Selection of high-affinity phage antibodies from phage display libraries. Nat Biotechnol 1999; 17:397-9.
18. Little M, Welschof M, Braunagel M, Hermes I, Christ C, Keller A, Rohrbach P, Kurschner T, Schmidt S, Kleist C, Terness P. Generation of a large complex antibody library from multiple donors. J Immunol Methods 1999; 231:3-9.
19. Vest Hansen N, Ostergaard Pedersen L, Stryhn A, Buus S. Phage display of peptide/major histocompatibility class I complexes. Eur J Immunol 2001; 31:32-8.
20. Burton DR, Barbas IIIrd CF , Person MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991; 88:10134-7.
21. Ding YL, Liu MY, Han W, Yang SL, Liu H, Gong Y. Application of phage-displayed single chain antibodies in western blot. Acta Biochim Biophys Sin (Shanghai) 2005; 37:205-9.
22. Schier R, Bye J, Apell G, McCall A, Adams GP, Malmqvist M, Weiner LM, Marks JD. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol 1996; 255:28-43.
23. Wells JA. Additivity of mutational effects in proteins. Biochemistry 1990; 29:8509-17.
24. Welschof M, Terness P, Kolbinger F, Zewe M, Dubel S, Dorsam H, Hain C, Finger M, Jung M, Moldenhauer G, Hayashi N, Little M, Opelz G. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immuneoglobulin variable region genes. J Immunol Methods 1995; 179:203-14.
25. Péneff C, Lefranc MP, Dariavach P. Characterisation and specificity of two single-chain Fv antibodies directed to the protein tyrosine kinase Syk. J Immunol Methods 2000; 236:105-15.
26. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115:888-99.
27. Schlaeppi JM, Wood JM. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors. Cancer Metastasis Rev 1999; 18:473-81.
28. Stein R, Juweid M, Mattes MJ, Goldenberg DM. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: Antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs. Cancer Biother Radiopharm 1999; 14:37-47.
29. Ishida T, Imai K. The expression technology of chimeric and humanized antibodies. Nippon Rinsho 2002; 60:439-44.
30. Zhang MY, Schillberg S, Zimmermann S, Liao YC, Breuer G, Fischer R. GST fusion proteins cause false positives during selection of viral movement protein specific single chain antibodies. J Virol Methods 2001; 91:139-47.
31. Mersmann M, Schmidt A, Tesar M, Schoneberg A, Welschof M, Kipriyanov S, Terness P, Little M, Pfizenmaier K, Moosmayer D. Monitoring of scFv selected by phage display using detection of scFv-pIII fusion proteins in a microtiter scale assay. J Immunol Methods 1998; 220:51-8.
32. Rojas G, Talavera A, Munoz Y, Rengifo E, Krengel U, Angstrom J, Gavilondo J, Moreno E. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside. J Immunol Methods 2004; 293:71-83.